Caffeine; the Forgotten Potential for Parkinson's Disease.
@article{Negida2017CaffeineTF, title={Caffeine; the Forgotten Potential for Parkinson's Disease.}, author={Ahmed Negida and Mohamed Elfil and Attia and Eslam Farahat and M. Gabr and A. Essam and D. Attia and H. Ahmed}, journal={CNS & neurological disorders drug targets}, year={2017}, volume={16 6}, pages={ 652-657 } }
BACKGROUND
Parkinson's disease (PD) is the second most common neurological disorder characterized by loss of dopaminergic fibers in the basal ganglia and presence of Lewy bodies.
METHOD AND RESULTS
The literature suggests that caffeine plays multiple roles in PD. Epidemiological studies showed that caffeine intake was associated with less risk of developing PD, especially in genetically susceptible patients. On the level of Lewy bodies' formation, caffeine binds to α-synuclein protein… CONTINUE READING
Topics from this paper
7 Citations
Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
- Medicine
- International journal of molecular sciences
- 2020
- 1
- PDF
Identification of potential natural neuroprotective molecules for Parkinson's disease by using chemoinformatics and molecular docking.
- Medicine
- Journal of molecular graphics & modelling
- 2020
- 2
Safety and Efficacy of Levetiracetam for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review.
- Medicine
- CNS & neurological disorders drug targets
- 2019
- 5
Mitophagy could fight Parkinson’s disease through antioxidant action
- Medicine, Chemistry
- Reviews in the neurosciences
- 2019
- 2
- PDF
ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
- Medicine
- Journal of clinical medicine
- 2021
Managing interactions between cognitive enhancers and other psychotropics
- Medicine
- International clinical psychopharmacology
- 2017